These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20382026)

  • 1. Where does amantadine bind to the influenza virus M2 proton channel?
    Kozakov D; Chuang GY; Beglov D; Vajda S
    Trends Biochem Sci; 2010 Sep; 35(9):471-5. PubMed ID: 20382026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel.
    Chuang GY; Kozakov D; Brenke R; Beglov D; Guarnieri F; Vajda S
    Biophys J; 2009 Nov; 97(10):2846-53. PubMed ID: 19917240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers.
    Cady SD; Schmidt-Rohr K; Wang J; Soto CS; Degrado WF; Hong M
    Nature; 2010 Feb; 463(7281):689-92. PubMed ID: 20130653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the function and inhibition of an influenza virus proton channel.
    Stouffer AL; Acharya R; Salom D; Levine AS; Di Costanzo L; Soto CS; Tereshko V; Nanda V; Stayrook S; DeGrado WF
    Nature; 2008 Jan; 451(7178):596-9. PubMed ID: 18235504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion channels: coughing up flu's proton channels.
    Miller C
    Nature; 2008 Jan; 451(7178):532-3. PubMed ID: 18235492
    [No Abstract]   [Full Text] [Related]  

  • 6. Why bound amantadine fails to inhibit proton conductance according to simulations of the drug-resistant influenza A M2 (S31N).
    Gleed ML; Busath DD
    J Phys Chem B; 2015 Jan; 119(3):1225-31. PubMed ID: 25426702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.
    Balannik V; Wang J; Ohigashi Y; Jing X; Magavern E; Lamb RA; Degrado WF; Pinto LH
    Biochemistry; 2009 Dec; 48(50):11872-82. PubMed ID: 19905033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
    Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray Crystal Structure of the Influenza A M2 Proton Channel S31N Mutant in Two Conformational States: An Open and Shut Case.
    Thomaston JL; Wu Y; Polizzi N; Liu L; Wang J; DeGrado WF
    J Am Chem Soc; 2019 Jul; 141(29):11481-11488. PubMed ID: 31184871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced conformational and dynamical changes of the S31N mutant of the influenza M2 proton channel investigated by solid-state NMR.
    Williams JK; Tietze D; Wang J; Wu Y; DeGrado WF; Hong M
    J Am Chem Soc; 2013 Jul; 135(26):9885-97. PubMed ID: 23758317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
    Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
    Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A secondary gate as a mechanism for inhibition of the M2 proton channel by amantadine.
    Yi M; Cross TA; Zhou HX
    J Phys Chem B; 2008 Jul; 112(27):7977-9. PubMed ID: 18476738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
    Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus.
    Salom D; Hill BR; Lear JD; DeGrado WF
    Biochemistry; 2000 Nov; 39(46):14160-70. PubMed ID: 11087364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus.
    Khurana E; Devane RH; Dal Peraro M; Klein ML
    Biochim Biophys Acta; 2011 Feb; 1808(2):530-7. PubMed ID: 20385097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between membrane curvature and protein conformational equilibrium investigated by solid-state NMR.
    Liao SY; Lee M; Hong M
    J Struct Biol; 2019 Apr; 206(1):20-28. PubMed ID: 29501472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.
    Du QS; Huang RB; Wang CH; Li XM; Chou KC
    J Theor Biol; 2009 Jul; 259(1):159-64. PubMed ID: 19285514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance-Mutation (N31) Effects on Drug Orientation and Channel Hydration in Amantadine-Bound Influenza A M2.
    Gleed ML; Ioannidis H; Kolocouris A; Busath DD
    J Phys Chem B; 2015 Sep; 119(35):11548-59. PubMed ID: 26268449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the M2 Proton Channel Engage and Disrupt Transmembrane Networks of Hydrogen-Bonded Waters.
    Thomaston JL; Polizzi NF; Konstantinidi A; Wang J; Kolocouris A; DeGrado WF
    J Am Chem Soc; 2018 Nov; 140(45):15219-15226. PubMed ID: 30165017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.